ATOME Management Team

Photograph: Saskia  Jünger
Dr. rer. medic. Saskia Jünger
University Hospital Bonn

Project Executive Officer, Health Scientist, Department of Palliative Medicine

Dr. Saskia Jünger is a health scientist and psychologist. She has coordinated scientific projects on behalf of the Ministry of Health of North Rhine-Westphalia (Germany) and the European Association for Palliative Care (EAPC). In recent years, she has been doing research in different projects with a Europe-wide perspective and with a focus on health services research. Since 2010 Saskia Jünger is conducting her PhD in Health Research at Lancaster University (UK) focusing on consensus building in palliative care within a multinational context.

Photograph: Eugenia Larjow
Eugenia Larjow
University Hospital Bonn

Project coordinator

Eugenia is a sociologist. During her activity at the Federal Statistical Office she has undertaken projects on behalf of the Federal Gorvernment/Ministry of Health focused on measuring the cost of bureaucracy. Since March 2014 she is pleased to be a member of the ATOME team at the University Hospital Bonn.

Photograph: Lisa Linge-Dahl
Lisa Linge-Dahl
University Hospital Bonn

Project Coordinator

Lisa is a psychcologist, having undertaken research work at the Universtity of Zurich on personality traits and work satisfaction. Since October 2013 she returned to Germany and is pleased to be working with ATOME colleagues at Universitätsklinikum Bonn.

Lisa has a coordinator role within the project.

Photograph: Sheila Payne
Professor Sheila Payne
Lancaster University

Director of the International Observatory on End of Life Care, Lancaster University
President of the European Association for Palliative Care
Telephone: +44 (0)1524 593701

Prof. Sheila Payne is a health psychologist and the Director of the International Observatory on End of Life Care at Lancaster Universtiy and holds the Help the Hospices Chair for Hospice Studies at the Institute for Health Research at Lancaster University since 2006. She is president of the European Association for Palliative Care. Professor Payne was involved in the development of several scientific and policy Guidelines in the area of palliative care.

Photograph: Lukas Radbruch
Professor Lukas Radbruch
University Hospital Bonn

Chair of Palliative Medicine at the Rheinische Friedrich-Wilhem University Bonn, Director of the Department of Palliative Care at the University Hospital Bonn and Director of the Department of Palliative Medicine at the Malteser Hospital Bonn/Rhein-Sieg
Telephone: +49-228-6481 9170

Professor Lukas Radbruch is the chair of palliative medicine at the University of Bonn, in the Western part of Germany. He has been the first chair of palliative medicine at the RWTH Aachen University in Aachen from 2003-2010. Professor Radbruch attended medical school in Bonn, Germany, specialized in anaesthesiology and completed his habilitation (the German equivalent of a PhD) in 2000 in Cologne.

His main research interests include symptom assessment, opioid treatment, fatigue, cachexia and ethical issues in palliative care. Professor Radbruch is involved in European palliative care research collaboratives and coordinates the project Access To Opioid Medication in Europe, which is funded by the Seventh Framework Programme of the European Commission.

He is past-president of the European Association for Palliative Care (EAPC), a board member of the International Association of Hospice and Palliative Care (IAHPC), a member of the International Faculty of the Institute of Palliative Medicine at San Diego Hospice and a member of the Drug Commission of the German Medical Board, the EAPC Research Network Steering Committee and the Expert Commission of the German Narcotic Control Agency. He also is editor of Der Schmerz (Impact factor 1.4).

Photograph: Willem  Scholten
Dr Willem Scholten

Consultant - Medicines and Controlled Substances, Speaker on behalf of WHO; former Team Leader, WHO Access to Controlled Medicines
Telephone: +41 22 79 15540

WHO is the directing and coordinating authority for health within the United Nations system. In 2007, WHO established the Access to Controlled Medications Programme in order to promote policies worldwide that balance the prevention of substance abuse and dependence with good access for rational medical use.


Map representations are for illustration purposes only and are not accurate representations of national boundaries.

Language translations, where provided, have not been verified. ATOME cannot be held responsible for inaccuracies in the translated word.

The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no 222994

© ATOME 2010-2014

Other pages within the site: